Literature DB >> 19253303

The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective.

María Fernández-Reyes1, Manuel Rodríguez-Falcón, Cristina Chiva, Jerónimo Pachón, David Andreu, Luis Rivas.   

Abstract

Colistin resistance in Acinetobacter baumannii, a pathogen of clinical concern, was induced in the susceptible strain ATCC 19606 by growth under increasing pressure of the antibiotic, the only drug universally active against multi-resistant clinical strains. In 2-D difference gel electrophoresis (DIGE) experiments, 35 proteins with differences in expression between both phenotypes were identified, most of them appearing as down regulated in the colistin-resistant strain. These include outer membrane (OM) proteins, chaperones, protein biosynthesis factors, and metabolic enzymes, all suggesting substantial loss of biological fitness in the resistant phenotype, as substantiated by complementary experiments in the absence of colistin. Results shed light on the scarcity of widespread clinical outbreaks for resistant phenotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19253303     DOI: 10.1002/pmic.200800434

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  44 in total

1.  Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.

Authors:  Bianca Dößelmann; Matthias Willmann; Matthias Steglich; Boyke Bunk; Ulrich Nübel; Silke Peter; Richard A Neher
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Impaired virulence and fitness of a colistin-resistant clinical isolate of Acinetobacter baumannii in a rat model of pneumonia.

Authors:  Sami Hraiech; Antoine Roch; Hubert Lepidi; Thérèse Atieh; Gilles Audoly; Jean-Marc Rolain; Didier Raoult; Jean-Michel Brunel; Laurent Papazian; Fabienne Brégeon
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

3.  Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

Authors:  Rafael López-Rojas; Michael J McConnell; Manuel Enrique Jiménez-Mejías; Juan Domínguez-Herrera; Felipe Fernández-Cuenca; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

4.  Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.

Authors:  Tatiana Bogdanovich; Jennifer M Adams-Haduch; Guo-Bao Tian; Minh Hong Nguyen; Eun Jeong Kwak; Carlene A Muto; Yohei Doi
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

5.  Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.

Authors:  Meritxell García-Quintanilla; Marina R Pulido; Patricia Moreno-Martínez; Reyes Martín-Peña; Rafael López-Rojas; Jerónimo Pachón; Michael J McConnell
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 6.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

7.  Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

Authors:  Alejandro Beceiro; Enrique Llobet; Jesús Aranda; José Antonio Bengoechea; Michel Doumith; Michael Hornsey; Hiran Dhanji; Henrik Chart; Germán Bou; David M Livermore; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

8.  An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.

Authors:  Alberto Oddo; Thomas T Thomsen; Susanne Kjelstrup; Ciara Gorey; Henrik Franzyk; Niels Frimodt-Møller; Anders Løbner-Olesen; Paul R Hansen
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

9.  Neisseria meningitidis rifampicin resistant strains: analysis of protein differentially expressed.

Authors:  Arianna Neri; Giuseppina Mignogna; Cecilia Fazio; Alessandra Giorgi; Maria Eugenia Schininà; Paola Stefanelli
Journal:  BMC Microbiol       Date:  2010-09-24       Impact factor: 3.605

10.  2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism.

Authors:  Nelson C Soares; Maria P Cabral; José R Parreira; Carmen Gayoso; Maria J Barba; Germán Bou
Journal:  Proteome Sci       Date:  2009-09-28       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.